Type 2 diabetes. Type 2 diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Having type 2 diabetes for at least 2 years Fasting blood glucose more than 126 mg / dL HbA1c less than 9% Vitamin D3 level less than 20 ng / ml
Exclusion criteria
Exclusion criteria: History of using medications such as insulin, calcium and vitamin D History of kidney, cardiovascular, liver and other diseases Age under 35 and over 60 Having a regular exercise activity one year before the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tumor Necrosis Factor-alpha (TNF-a). Timepoint: Before the intervention and 12 week after. Method of measurement: Serum levels were measured by the ELISA method and by biochemical kits, Diaclone , France.;Interleukin-6 (IL-6). Timepoint: Before the intervention and 12 week after. Method of measurement: Serum levels were measured by the ELISA method and by biochemical kits, Diaclone , France.;C-Reactive Protein. Timepoint: Before the intervention and 12 week after. Method of measurement: Serum levels were measured by the ELISA method and by biochemical kits, Roche Diagnostics Company, Swiss. | — |
Secondary
| Measure | Time frame |
|---|---|
| Loss weight. Timepoint: Before intervention and 12 weeks after that. Method of measurement: With Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Islamic Azad University